scholarly article | Q13442814 |
P819 | ADS bibcode | 2000PNAS...97.2591N |
P356 | DOI | 10.1073/PNAS.050282397 |
P932 | PMC publication ID | 15973 |
P698 | PubMed publication ID | 10688905 |
P5875 | ResearchGate publication ID | 12626462 |
P50 | author | Luc Maroteaux | Q42416039 |
P2093 | author name string | Launay JM | |
Nebigil CG | |||
Hickel P | |||
Tournois C | |||
P2860 | cites work | A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation | Q24312845 |
Ras involvement in signal transduction by the serotonin 5-HT2B receptor | Q28277869 | ||
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein | Q28305440 | ||
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo | Q28609356 | ||
Cellular functions regulated by Src family kinases | Q29616038 | ||
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation | Q29617586 | ||
Src family kinases are required for integrin but not PDGFR signal transduction. | Q30014832 | ||
Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells | Q36230241 | ||
Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution | Q36569390 | ||
c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. | Q38352423 | ||
Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. | Q40805758 | ||
Functional co-operation between the subunits in heterodimeric platelet-derived growth factor receptor complexes. | Q40940164 | ||
Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis. | Q41063150 | ||
Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels | Q41069274 | ||
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. | Q41115396 | ||
Angiotensin II activation of cyclin D1-dependent kinase activity | Q41168284 | ||
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. | Q41173912 | ||
Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases | Q41175767 | ||
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors | Q41229236 | ||
Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation | Q41365744 | ||
Differential regulation of fyn-associated protein tyrosine kinase activity by macrophage colony-stimulating factor (M-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF). | Q42490112 | ||
Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway. | Q42643173 | ||
Tyrphostins. 5. Potent inhibitors of platelet-derived growth factor receptor tyrosine kinase: structure-activity relationships in quinoxalines, quinolines, and indole tyrphostins | Q42812895 | ||
Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein | Q44728767 | ||
A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases | Q44980958 | ||
Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells | Q47886642 | ||
The expanding role of cell cycle regulators | Q48005050 | ||
Angiotensin II Controls p21 Activity via pp60 | Q57630605 | ||
Thrombin Stimulates Phosphorylation of Insulin-like Growth Factor-1 Receptor, Insulin Receptor Substrate-1, and Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells | Q57908184 | ||
Molecular biology of serotonin receptors | Q70153043 | ||
Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin | Q71602100 | ||
Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells | Q72259808 | ||
Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction | Q74064551 | ||
An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression | Q77408757 | ||
Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases | Q77726430 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 6 | |
P304 | page(s) | 2591-2596 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways | |
P478 | volume | 97 |
Q36874372 | 5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves. |
Q42424976 | 5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation |
Q46472658 | 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats |
Q52572352 | A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction. |
Q28569215 | A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis |
Q34433942 | A role for the serotonin transporter in hypoxia-induced pulmonary hypertension |
Q45926662 | Amyloid beta-derived neuroplasticity in bone marrow-derived mesenchymal stem cells is mediated by NPY and 5-HT2B receptors via ERK1/2 signalling pathways. |
Q33822451 | Bioelectric controls of cell proliferation: ion channels, membrane voltage and the cell cycle |
Q41964119 | Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension |
Q46950657 | Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors |
Q50044005 | Cell Proliferation and Migration Mechanism of Caffeoylserotonin and Serotonin via Serotonin 2B receptor in Human Keratinocyte HaCaT cells |
Q39175786 | Clinical signs of fibrosis in small intestinal neuroendocrine tumours |
Q36223175 | Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs |
Q34264903 | Developmentally regulated serotonin 5-HT2B receptors. |
Q44578132 | Different pharmacological properties of two equipotent antagonists (clozapine and rauwolscine) for 5-HT2B receptors in rat stomach fundus |
Q43244103 | Differential expression of vasoactive mediators in microparticle-challenged lungs of chickens that differ in susceptibility to pulmonary arterial hypertension |
Q44910197 | Differential regulation of chondrogenic differentiation by the serotonin2B receptor and retinoic acid in the embryonic mouse hindlimb |
Q35460340 | Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy. |
Q35076576 | Evolutionary forward genomics reveals novel insights into the genes and pathways dysregulated in recurrent early pregnancy loss |
Q44523604 | Expression of 5-HT2B and 5-HT2C receptor genes is associated with proliferative regions of Xenopus developing brain and eye. |
Q49350480 | Expression of components of the serotonergic system in the developing rat thymus |
Q43626712 | Expression of serotonin receptors in bone |
Q52716559 | Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines. |
Q34658528 | Fibrosis and carcinoid syndrome: from causation to future therapy |
Q46402539 | Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation |
Q28203160 | Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension |
Q34653768 | Functions of serotonin in hypoxic pulmonary vascular remodeling |
Q42248397 | Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. |
Q40907826 | Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway |
Q43691081 | Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component |
Q46096606 | Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems |
Q47191844 | Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis. |
Q40482195 | Modulation of serotonergic receptor signaling and cross-talk by prion protein. |
Q28210479 | Multiplicity of mechanisms of serotonin receptor signal transduction |
Q47720153 | Neuroendocrine tumors and fibrosis: An unsolved mystery? |
Q44660819 | Norepinephrine activates extracellular-regulated kinase in cortical neurons |
Q48130563 | Pulmonary fibrosis in vivo displays increased p21 expression reduced by 5-HT2B receptor antagonists in vitro - a potential pathway affecting proliferation |
Q30530379 | Resting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivo |
Q40696751 | Role for cellular Src kinase in myoblast proliferation |
Q36544945 | Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on 'fen-phen'. |
Q39998939 | Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells |
Q49975788 | Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice |
Q35919662 | Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension |
Q42629276 | Serotonin 2B receptor (5-HT2B R) signals through prostacyclin and PPAR-ß/δ in osteoblasts |
Q28594131 | Serotonin 2B receptor is required for heart development |
Q34143560 | Serotonin Receptors – From Molecular Biology to Clinical Applications |
Q39772652 | Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines |
Q43681023 | Serotonin activation of the ERK pathway in Hermissenda: contribution of calcium-dependent protein kinase C. |
Q38634250 | Serotonin and catecholamines in the development and progression of heart valve diseases. |
Q44615703 | Serotonin and the cardiovascular system: role of the serotoninergic 5-HT 2B receptor |
Q44643430 | Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization |
Q24685016 | Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells |
Q38231265 | Serotonin modulation of macrophage polarization: inflammation and beyond |
Q37132811 | Serotonin pharmacology in the gastrointestinal tract: a review |
Q34173511 | Serotonin receptors and heart valve disease--it was meant 2B. |
Q39457123 | Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors |
Q28289039 | Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors |
Q34121796 | The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment |
Q35584090 | The developmental role of serotonin: news from mouse molecular genetics |
Q36415999 | The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis |
Q34770217 | The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity |
Q24337088 | The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions |
Q33617543 | The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation |
Q34233512 | Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12. |
Q34435259 | Transmembrane potential of GlyCl-expressing instructor cells induces a neoplastic-like conversion of melanocytes via a serotonergic pathway. |
Search more.